Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt

Oral Oncology

Volumn 45, Issue 2, 2009, Pages 156-163

  Hu, Kai ^a   Li, Sheng lin ^a   Gan, Ye hua ^a   Wang, Cun yu ^b   Yu, Guang yan ^a  

^a PEKING UNIVERSITY   (China)

^b UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Akt; Epiregulin; ERK1 2; Metastasis; Salivary adenoid cystic carcinoma

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLOOXYGENASE 2; EPIREGULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TRANSCRIPTOME;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MICROARRAY ANALYSIS; MOLECULE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY ADENOID CYSTIC CARCINOMA; SALIVARY GLAND CARCINOMA; VALIDATION STUDY;

CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOOXYGENASE 2 INHIBITORS; EPIDERMAL GROWTH FACTOR; HUMANS; LUNG NEOPLASMS; MICROARRAY ANALYSIS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS;

EID: 58749099461     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.04.009     Document Type: Article

References (41)

1. Szanto P.A., Luna M.A., Tortoledo E., and White R.A. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 54 6 (1984) 1062-1069
2. Zhang J.L., Peng B., and Chen X.M. Expressions of nuclear factor kappa B, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11 20 (2005) 7334-7343
3. Sung M.W., Kim K.H., Kim J.W., Min Y.G., Scong W.J., Roh J.L., et al. Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129 11 (2003) 1193-1197
4. Li S.L., Liu X.P., and Zhang K.H. Establishment of a human cancer cell line from adenoid cystic carcinoma of the minor salivary gland. Zhonghua Kou Qiang Yi Xue Za Zhi 25 1 (1990) 29-31 62
5. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 6 (2003) 453-458
6. Yokota J. Tumor progression and metastasis. Carcinogenesis 21 3 (2000) 497-503
7. Toyoda H., Komurasaki T., Uchida D., Takayama Y., Isobe T., Okuyama T., et al. Epiregulin: a novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270 13 (1995) 7495-7500
8. Toyoda H., Komurasaki T., Uchida D., and Morimoto S. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 326 1 (1997) 69-75
9. Riese II D.J., Komurasaki T., Plowman G.D., and Stern D.F. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J Biol Chem 273 18 (1998) 11288-11294
10. Shelly M., Pinkas-Kramarski R., Guarino B.C., Waterman H., Wang L.M., Lyass L., et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem 273 17 (1998) 10496-10505
11. Citri A., and Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7 7 (2006) 505-516
12. Yoon S., and Seger Y. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24 1 (2006) 21-44
13. Osaki M., Oshimura M., and Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9 6 (2004) 667-676
14. Luo J., Manning B.D., and Cantley L.C. Targeting the P13K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 4 (2003) 257-262
15. Zeng Q., McCauley L.K., and Wang C.Y. Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2 - implication in head and neck squamous cell carcinoma progression. J Biol Chem 277 51 (2002) 50137-50142
16. ΔΔCT method. Methods 25 4 (2001) 402-408
17. Yoshikawa M., Kojima H., Wada K., Tsukidate T., Okada N., Saito H., et al. Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 132 7 (2006) 734-742
18. Zhang Z., Reenstra W., Weiner D.J., Louboutin J.P., and Wilson J.M. The p38 mitogen-activated protein kinase signaling pathway is coupled to toll-like receptor 5 to mediate gene regulation in response to Pseudomonas aeruginosa infection in human airway epithelial cells. Infect Immun 75 12 (2007) 5985-5992
19. Wang V., Davis D.A., Haque M., Huang L.E., and Yarchoan R. Differential gene up-regulation by hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in HEK293T cells. Cancer Res 65 8 (2005) 3299-3306
20. Dowen S.E., Crnogorac-Jurcevic T., Gangeswaran R., Hansen M., Eloranta J.J., Bhakta V., et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 166 1 (2005) 81-92
21. Dveksler G.S., Basile A.A., and Dieffenbach C.W. Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR Methods Appl 1 4 (1992) 283-285
22. Zeng Q.H., Chen S.Q., You Z.B., Yang F., Carey T.E., Saims D., et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NF kappa B. J Biol Chem 277 28 (2002) 25203-25208
23. Nicholson B.E., Frierson H.F., Conaway M.R., Seraj J.M., Harding M.A., Hampton G.M., et al. Profiling the evolution of human metastatic bladder cancer. Cancer Res 64 21 (2004) 7813-7821
24. Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446 7137 (2007) 765-770
25. Katz M., Amit I., and Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta-Mol Cell Res 1773 8 (2007) 1161-1176
26. Draper B.K., Komurasaki T., Davidson M.K., and Nanney L.B. Epiregulin is more potent than EGF or TGFalpha in promoting in vitro wound closure due to enhanced ERK/MAPK activation. J Cell Biochem 89 6 (2003) 1126-1137
27. Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem 386 3 (2005) 193-205
28. Reddy K.B., Nabha S.M., and Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22 4 (2003) 395-403
29. de Melo M., Gerbase M.W., Curran J., and Pache J.C. Phosphorylated extracellular signal-regulated kinases are significantly increased in malignant mesothelioma. J Histochem Cytochem 54 8 (2006) 855-861
30. Adeyinka A., Nui Y., Cherlet T., Snell L., Watson P.H., and Murphy L.C. Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res 8 6 (2002) 1747-1753
31. Shaw L.M., Rabinovitz I., Wang H.H., Toker A., and Mercurio A.M. Activation of phosphoinositide 3-OH kinase by the alpha 6 beta 4 integrin promotes carcinoma invasion. Cell 91 7 (1997) 949-960
32. Park B.K., Zeng X., and Glazer R.I. Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res 61 20 (2001) 7647-7653
33. Yoeli-Lerner M., Yiu G.K., Rabinovitz I., Erhardt P., Jauliac S., and Toker A. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20 4 (2005) 539-550
34. Irie H.Y., Pearline R.V., Grueneberg D., Hsia M., Ravichandran P., Kothari N., et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171 6 (2005) 1023-1034
35. Chen P., Xie H., Sekar M.C., Gupta K., and Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127 3 (1994) 847-857
36. Andl C.D., Mizushima T., Oyama K., Bowser M., Nakagawa H., and Rustgi A.K. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am J Physiol Gastroint Liver Physiol 287 6 (2004) G1227-G1237
37. Tsujii M., Kawano S., and DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94 7 (1997) 3336-3340
38. Basu G.D., Pathangey L.B., Tinder T.L., Lagioia M., Gendler S.J., and Mukherjee P. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Mol Cancer Res 2 11 (2004) 632-642
39. Singh B., Berry J.A., Vincent L.E., and Lucci A. Involvement of IL-8 in COX-2 mediated bone metastases from breast cancer. J Surg Res 134 1 (2006) 44-51
40. Takaoka K., Kishimoto H., Segawa E., Hashitani S., Zushi Y., Noguchi K., et al. Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA. Int J Oncol 29 5 (2006) 1095-1101
41. Singh B., Berry J.A., Shoher A., Ramakrishnan V., and Lucci A. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 26 5 (2005) 1393-1399